Bangkok Lab And Cosmetic PCL (BKK:BLC)

Market Cap	2.40B -2.0%
Revenue (ttm)	1.68B +6.3%
Net Income	173.02M +1.0%
EPS	0.29
Shares Out	600.00M
PE Ratio	13.79
Forward PE	n/a
Dividend	0.25 (6.25%)
Ex-Dividend Date	Apr 9, 2026

Volume	633,727
Average Volume	509,569
Open	3.920
Previous Close	3.880
Day's Range	3.880 - 4.000
52-Week Range	3.380 - 5.200
Beta	0.39
RSI	61.68
Earnings Date	May 13, 2026

About BKK:BLC

Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. It distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. The company also engages in provision of management consulting and logistic services; export and distribution of cosmeceuticals; wholesale and ret...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1992
• Employees: 947
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BLC

Financial Performance

In 2025, BKK:BLC's revenue was 1.68 billion, an increase of 6.31% compared to the previous year's 1.58 billion. Earnings were 173.02 million, an increase of 0.97%.